Wiskott–Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation

Centre for Immunodeficiency, UCL Institute of Child Health, London, UK.
Immunobiology (Impact Factor: 3.18). 08/2009; 214(9-10):778-90. DOI: 10.1016/j.imbio.2009.06.009
Source: PubMed

ABSTRACT Regulation of the actin cytoskeleton is crucial for many aspects of correct and cooperative functioning of immune cells, such as migration, antigen uptake and cell activation. The Wiskott-Aldrich Syndrome protein (WASp) is an important regulator of actin cytoskeletal rearrangements and lack of this protein results in impaired immune function. This review discusses recent new insights of the role of WASp at molecular and cellular level and evaluates how WASp deficiency affects important immunological features and how defective immune cell function contributes to compromised host defence.


Available from: Gerben Bouma, May 29, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Podosomes are integrin-containing adhesion structures commonly found in migrating leukocytes of the monocytic lineage. The actin cytoskeletal organisation of podosomes is based on a WASP-Arp2/3 mediated mechanism. WASP also associates with a second protein, WIP, where they co-localise in podosome cores. Here we report for the first time that WIP can be phosphorylated on tyrosine residues and that tyrosine phosphorylation of WIP is a trigger for release of WASP from the WIP-WASP complex. Using a knockdown approach together with expression of WIP phosphomimics, we show that in the absence of WIP-WASP binding, cellular WASP is rapidly degraded, leading to disruption of podosomes and a failure of cells to degrade an underlying matrix. In the absence of tyrosine phosphorylation, the WIP-WASP complex remains intact and podosome lifetimes are extended. A screen of candidate kinases and inhibitor-based assays identified Bruton's tyrosine kinase as a regulator of WIP tyrosine phosphorylation. We conclude that tyrosine phosphorylation of WIP is a critical regulator of WASP stability and function as an actin nucleation promoting factor.
    Journal of Cell Science 11/2014; 128(2). DOI:10.1242/jcs.154880 · 5.33 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: et al. Hypoxia: A Key Feature of the Tumor Microenvironment Triggers Several Mechanisms of Evasion from Natural Killer and Cytotoxic T Lymphocytes Surveillance. J Immun Res. 2014;1(2): 8. J Immun Res -Volume 1 Issue 2 -2014 Submit your Manuscript | Janji et al. © All rights are reserved Abstract Since many years, the tumor microenvironment is recognized as an important promoter of cancer initiation and progression. Although tumors primarily consist in cancer cells, various components/factors of the microenvironment and more specifically the immune landscape, dramatically impact cancer progression. Comprehensive analyses conducted on diverse tumors have identified and characterized the most relevant components/ factors of the tumor microenvironment that supports the malignant behavior of a growing primary tumor. Tumor hypoxia is a common characteristic of the tumor microenvironment that is associated with tumor progression, metastasis, treatment failure and escape from immune surveillance. Although immune cells are usually efficiently recruited into the tumor bed, hypoxic microenvironment was reported to compromise immune cell functions and, in some cases, switch immune cell activity towards a pro-tumorigenic profile. Mechanistic studies have highlighted that hypoxia acts as double-edged sword: it simultaneously impairs the function of immune cells in the tumor microenvironment and activates intrinsic cell resistance mechanisms in tumor cells. The present article aims at reviewing some recent findings on how hypoxia impairs the anti-tumor immune response by focusing on emerging mechanisms by which hypoxia damps the function of immune effectors cells and activates intrinsic immune resistance mechanisms in tumor cells including autophagy and actin cytoskeleton remodeling. cancer immune surveillance which predicts that the immune system can recognize precursors of cancer and, in most cases, destroy them or slow their growth before they become clinically apparent [1, 2]. Several types of immune cells are involved in tumor immune surveillance. Briefly, key cells of the adaptive immune system recognizing cancer cells are cytotoxic T lymphocytes (CTL) which are able to identify tumor antigens via the T cell receptor (TCR) [3]. Some of these antigens are expressed exclusively by tumors and thus are called tumor-specific antigens [3]. Natural killer (NK) cells of the innate immune system also play an important role in tumor immune surveillance [3] by mechanisms called "missing-self" and "induced-self" recognitions [5]. In addition to CTL and NK cells, macrophages and neutrophil granulocytes are also involved in anti-tumor immunity [6]. Macrophages are antigen presenting cells (APCs) that display tumor antigens and stimulate other immune cells such as CTL, NK cells and other APCs [7]. While the molecular mechanism by which CTL and NK cells recognize their target tumor cells is fundamentally different, both immune cells kill their target following the establishment of immunological synapse (IS) [8]. The formation of IS requires cell polarization and extensive remodeling of the actin cytoskeleton at various stages [9]. It is now well established that CTL and NK cells recognize and kill target cells by two major pathways: either through the release of cytotoxic granules containing perforin and granzymes to the cytosol of target cells [10],
  • [Show abstract] [Hide abstract]
    ABSTRACT: Macrophages are professional migrating cells found in all body tissues from the early embryonic stages till the end of the adult life. Tissue macrophages do not only play beneficial roles. In several diseases, macrophages recruited from blood monocytes have a deleterious action such as favoring cancer progression and destroying tissues in chronic inflammation. To migrate in 3D environments, all leukocytes use the amoeboid movement while macrophages use the amoeboid and the mesenchymal migration modes. Mesenchymal migration takes place in dense matrices and involves podosomes and proteolysis of the extracellular matrix to create paths. Podosome disruption has been correlated with reduced mesenchymal migration of macrophages and unaffected amoeboid migration. Therefore, podosomes are proposed as a therapeutic target. Inhibiting podosome regulators that are only expressed in macrophages and few cell types would avoid collateral effects often encountered when ubiquitous proteins are used as drug targets. With the current status of our knowledge on human macrophage podosomes and 3D migration, the tyrosine kinase Hck appears to be a good candidate.
    Immunological Reviews 11/2014; 262(1). DOI:10.1111/imr.12214 · 12.91 Impact Factor